Fuji Pharma Balance Sheet

Financials in millions JPY. Fiscal year is October - September.

Millions JPY. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Equivalents	3,393	7,245	4,585	2,324	3,546	10,199
Cash & Short-Term Investments	3,393	7,245	4,585	2,324	3,546	10,199
Cash Growth	-8.20%	58.02%	97.29%	-34.46%	-65.23%	-15.30%
Accounts Receivable	23,247	17,987	18,426	16,304	12,527	11,866
Other Receivables	242	296	453	216	134	118
Receivables	23,489	18,283	18,879	16,520	12,661	11,984
Inventory	22,473	21,215	18,005	19,371	15,823	12,006
Other Current Assets	1,353	1,170	999	899	2,697	645
Total Current Assets	50,708	47,913	42,468	39,114	34,727	34,834
Property, Plant & Equipment	20,960	20,914	20,911	20,547	18,762	14,392
Long-Term Investments	3,359	8,308	13,036	14,702	10,211	11,265
Goodwill	-	-	88	412	691	865
Other Intangible Assets	13,945	13,941	12,356	10,081	9,713	1,532
Long-Term Deferred Tax Assets	2,807	2,327	1,139	475	1,432	1,349
Other Long-Term Assets	3,301	2	2	1	2	2
Total Assets	95,080	93,405	90,000	85,332	75,538	64,239
Accounts Payable	6,824	4,570	4,140	5,672	6,249	5,713
Accrued Expenses	580	1,105	560	883	990	982
Short-Term Debt	15,600	15,300	15,300	11,300	8,300	7,000
Current Portion of Long-Term Debt	1,931	1,981	7,100	5,210	2,440	1,840
Current Portion of Leases	586	582	569	514	377	681
Current Income Taxes Payable	563	963	1,567	484	444	823
Other Current Liabilities	6,240	6,487	6,561	5,708	5,175	3,153
Total Current Liabilities	32,324	30,988	35,797	29,771	23,975	20,192
Long-Term Debt	8,378	8,952	1,583	8,683	11,193	6,633
Long-Term Leases	3,973	4,122	4,702	3,241	2,259	2,508
Pension & Post-Retirement Benefits	2,260	2,215	2,130	1,863	1,766	1,657
Other Long-Term Liabilities	196	222	227	598	541	570
Total Liabilities	47,131	46,499	44,439	44,156	39,734	31,560
Common Stock	3,904	3,904	3,799	3,799	3,799	3,799
Additional Paid-In Capital	4,511	4,511	4,406	4,409	4,409	4,409
Retained Earnings	35,919	36,219	34,256	29,082	26,546	24,628
Treasury Stock	-480	-498	-505	-567	-579	-590
Comprehensive Income & Other	4,091	2,767	3,602	4,451	1,627	432
Total Common Equity	47,945	46,903	45,558	41,174	35,802	32,678
Minority Interest	4	3	3	2	2	1
Shareholders' Equity	47,949	46,906	45,561	41,176	35,804	32,679
Total Liabilities & Equity	95,080	93,405	90,000	85,332	75,538	64,239
Total Debt	30,468	30,937	29,254	28,948	24,569	18,662
Net Cash (Debt)	-27,075	-23,692	-24,669	-26,624	-21,023	-8,463
Net Cash Per Share	-1107.97	-970.86	-1014.74	-1095.58	-865.39	-315.00
Filing Date Shares Outstanding	24.47	24.46	24.31	24.3	24.29	24.29
Total Common Shares Outstanding	24.47	24.46	24.31	24.3	24.29	24.29
Working Capital	18,384	16,925	6,671	9,343	10,752	14,642
Book Value Per Share	1959.36	1917.91	1873.87	1694.21	1473.66	1345.50
Tangible Book Value	34,000	32,962	33,114	30,681	25,398	30,281
Tangible Book Value Per Share	1389.47	1347.85	1362.03	1262.45	1045.42	1246.81
Order Backlog	-	2,540	1,697	1,672	1,313	213

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.